This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record.

July 6, 2024

Reassessed

• CP 47,497 ( talk) reassessed. Quality rating changed from Stub-Class to Start-Class. ( rev · t) Importance rating changed from Unknown-Class to Low-Class. ( rev · t)
• Sedaxane ( talk) reassessed. Quality rating changed from Start-Class to C-Class. ( rev · t)

Assessed

• Fermagate ( talk) assessed. Quality assessed as Stub-Class. ( rev · t) Importance assessed as Low-Class. ( rev · t)
• RALES (trial) ( talk) assessed. Quality assessed as Start-Class. ( rev · t) Importance assessed as Low-Class. ( rev · t)

Removed

• Draft:Zosurabalpin ( talk) removed.

July 4, 2024

Assessed

• Deprenyl ( talk) assessed. Quality assessed as Unassessed-Class. ( rev · t) Importance assessed as Unknown-Class. ( rev · t)

Removed

• Draft:Clynxx ( talk) removed.

July 3, 2024

Reassessed

• Donanemab ( talk) reassessed. Importance rating changed from Low-Class to Mid-Class. ( rev · t)
• Gonadotropin-releasing hormone ( talk) reassessed. Quality rating changed from Start-Class to C-Class. ( rev · t)

Assessed

• Draft:Eunice Ego Mgbeahuruike ( talk) assessed. Importance assessed as NA-Class. ( rev · t)

July 2, 2024

Assessed

• Draft:LAPaL ( talk) assessed. Importance assessed as NA-Class. ( rev · t)

July 1, 2024

Reassessed

• Androgen (medication) ( talk) reassessed. Quality rating changed from Unassessed-Class to List-Class. ( rev · t)
• Bex (compound analgesic) ( talk) reassessed. Quality rating changed from Unassessed-Class to C-Class. ( rev · t)
• Compound management ( talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. ( rev · t)
• Levomoramide ( talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. ( rev · t)
• Molecule-based magnets ( talk) reassessed. Quality rating changed from Unassessed-Class to C-Class. ( rev · t)
• Nanocell ( talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. ( rev · t)
• Polymer-drug conjugates ( talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. ( rev · t)
• Protide ( talk) reassessed. Quality rating changed from Unassessed-Class to C-Class. ( rev · t)
• Seidlitz powders ( talk) reassessed. Quality rating changed from Unassessed-Class to C-Class. ( rev · t)

Assessed

• Luozi Pharmaceutical Research Center ( talk) assessed. Quality assessed as Stub-Class. ( rev · t) Importance assessed as Unknown-Class. ( rev · t)

June 30, 2024

Renamed

• Pharmaceutical industry in Switzerland renamed to Life sciences industry in Switzerland.

Reassessed

• Evolocumab ( talk) reassessed. Importance rating changed from Low-Class to Mid-Class. ( rev · t)

Assessed

• Gamithromycin ( talk) assessed. Quality assessed as Stub-Class. ( rev · t) Importance assessed as Mid-Class. ( rev · t)
• Life sciences industry in Switzerland ( talk) assessed. Quality assessed as C-Class. ( rev · t) Importance assessed as Unknown-Class. ( rev · t)
• Maropitant ( talk) assessed. Quality assessed as Start-Class. ( rev · t) Importance assessed as Mid-Class. ( rev · t)
• Scioderm ( talk) assessed. Quality assessed as Start-Class. ( rev · t) Importance assessed as Low-Class. ( rev · t)
• Selamectin ( talk) assessed. Quality assessed as Start-Class. ( rev · t) Importance assessed as Mid-Class. ( rev · t)